β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells: CONCLUSIONS: Our results indicate that active β-catenin signaling inhibits NK cell-mediated immune responses against… ht
RT @FrontImmunol: New Research: β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-…
New Research: β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells: Introduction BRAFV600E mutations frequently occur in papillary thyroid cancer (PTC).… #immunology https:/